Envestnet Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Envestnet Asset Management’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$584K	Buy	14,239 +4,383	+44%	+$159K	﹤0.01%	3967
2026 Q1	$300K	Sell	9,856 -6,171	-39%	-$204K	﹤0.01%	4274
2025 Q4	$575K	Buy	16,027 +2,533	+19%	+$77.3K	﹤0.01%	3609
2025 Q3	$325K	Buy	+13,494	New	+$282K	﹤0.01%	4025
2024 Q3	–	Sell	-41,695	Closed	-$672K	–	4268
2024 Q2	$672K	Sell	41,695 -13,230	-24%	-$239K	﹤0.01%	3283
2024 Q1	$1.18M	Buy	54,925 +32,520	+145%	+$611K	﹤0.01%	2919
2023 Q4	$342K	Sell	22,405 -33,830	-60%	-$601K	﹤0.01%	3541
2023 Q3	$1.3M	Sell	56,235 -25,443	-31%	-$580K	﹤0.01%	2620
2023 Q2	$1.95M	Buy	+81,678	New	+$1.87M	﹤0.01%	2296

Other funds holding INDV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Envestnet Asset Management's INDV Position: Q2 2026 in Review

Envestnet Asset Management increased its Indivior Pharmaceuticals (INDV) stake by 44% in Q2 2026, buying an estimated $159K and bringing the position to 14,239 shares worth $584K. The position accounts for ﹤0.01% of the portfolio, ranked #3967.

Envestnet Asset Management first reported a position in INDV in Q2 2023 and has held it in 9 quarters since. The position peaked at $1.95M in Q2 2023. 97 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Envestnet Asset Management held 14,239 shares of Indivior Pharmaceuticals worth $584K as of Q2 2026.
Envestnet Asset Management bought 4,383 Indivior Pharmaceuticals shares in Q2 2026, an estimated $159K.
Indivior Pharmaceuticals made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3967 holding.
Envestnet Asset Management first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 9 quarters since.
Envestnet Asset Management's Indivior Pharmaceuticals position peaked at $1.95M in Q2 2023.
97 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.